期刊文献+

抗精神病药对精神分裂症患者血小板腺苷A2a受体基因表达的影响 被引量:2

Effects of antipsychotics on platelet adenosine A2a receptor gene expression in un.medicated patients with schizophrenia
原文传递
导出
摘要 目的探讨未用药精神分裂症患者治疗前后血小板腺苷A2a受体(ADA2aR)mRNA表达量的变化及其与临床症状的相关性。方法采用实时定量聚合酶链反应技术,对30例未用药精神分裂症患者(患者组)治疗前和治疗6周后进行血小板ADA2aR mRNA表达量测定,并与30名健康志愿者(对照组)进行比较;采用Pearson相关分析对患者组血小板ADA2aR mRNA表达量与精神分裂症临床症状进行相关性分析。结果(1)治疗前,患者组血小板ADA2aR mRNA表达量(747.6±282.3)与对照组(692.7±286.7)比较,差异无统计学意义(P〉0.05);治疗第6周末,患者组血小板ADA2aR mRNA表达量(873.2±206.2)高于对照组(635.4±263.2)及患者组治疗前,差异均有统计学意义(P〈0.05)。(2)患者组治疗前血小板ADA2aR mRNA表达量与病程(r:0.17)、PANSS总分(r=0.08)、阳性症状(r=-0.12)、阴性症状(r=0.08)、一般病理症状(r=0.12)均无统计学相关性(P〉0.05);治疗第6周末,患者组血小板ADA2aR mRNA表达量与病程PANSS总分(r=0.09)、阳性症状(r=-0.02)、阴性症状(r=0.26)、一般病理症状(r=-0.08)亦无统计学相关性(P〉0.05);患者组治疗前后血小板ADA2aR mRNA表达量差值与PANSS总分减分值(r=-0.31)、阳性症状减分值(r=-0.28)、阴性症状减分值(r=-0.14)、一般病理症状减分值(r=-0.11)均无统计学相关性(P〉0.05)。结论抗精神病药治疗可能对精神分裂症患者外周血小板ADA2aR基因表达产生影响,血小板ADA2aR基因表达变化可能与精神分裂症临床症状无明显联系。 Objective To explore the effects of antipsychotics on peripheric platelet mRNA level of adenosine A2a receptor (ADA2aR) in un-medicated patients with schizophrenia. Methods The mRNA level of ADA2aR in 30 un-medicated patients with schizophrenia was evaluated with real-time polymerase chain reaction (RT-PCR) at baseline and after six-week antipsychotic treatment, and 30 healthy volunteers were examined as controls. Results There were no significant difference ( P 〉 0. 05 ) in the mRNA level of ADA2aR between schizophrenics (747.6 ±282. 3 ) and controls (692. 7 ± 286. 7 ) at baseline. There were also no significant correlation between mRNA level of ADA2aR and scores of Positive and Negative Symptoms Scales ( PANSS ) ( P 〉 0. 05 ) at baseline. After six-week antipsychotic treatment, the mRNA level of ADA2aR in schizophrenics ( 873.2 ± 206. 2 ) were significantly higher than the baseline ( 747.6 ± 282. 3 ) and in controls ( 635.4 ± 263.2 ) ( all P 〈 0. 05 ). No significant correlation between the mRNA level of ADA2aR and PANSS scores were found in schizophrenics and controls at baseline and endpoint ( P 〉 0. 05 ). There were also no significant correlation between changes in the mRNA level of ADA2aR and PANSS scores ( P 〉 0. 05 ) in schizophrenics and controls. Conclusions The results suggested that antipsychotics treatment have effect on the gene expression level of adenosine A2a receptor on platelet and changes in gene expression level of adenosine A2a receptor could have no relationship with clinical symptom of schizophrenics.
出处 《中华精神科杂志》 CAS CSCD 北大核心 2011年第4期197-201,共5页 Chinese Journal of Psychiatry
基金 国家自然科学基金面上项目(30670756) 国家自然科学基金重点项目(30930027)
关键词 精神分裂症 腺苷 抗精神病药 血小板 基因表达 Schizophrenia Adenosine Antipsychotic agents Blood platelets Gene expression
  • 相关文献

参考文献18

  • 1Dunwiddie TV, Masino SA. The role and regulation of' adenosine in the central nervous system. Annu Rev Neurosci, 2001,24: 31- 55.
  • 2Deekert J, Brenner M, Durany N, et al. Up-regulation of striatal adenosine A(2A) receptors in schizophrenia. Neuroreport, 2003, 14: 313-316.
  • 3Okamura N, Hashimoto K, Shimizu E, et al. Adenosine AI receptor agonists block the neuropathological changes in rat retrosplenial cortex after administration of the NMDA receptor antagonist dizocilpine. Neuropsychopharmaeology, 2004, 29: 544-550.
  • 4Wang JH, Short J, Ledent C, et al. Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor. Behav Brain Res, 2003, 143: 201-207.
  • 5Ferre S, Ciruela F, Canals M, et al. Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psyehiatric disorders. Parkinsonism Relat Disord, 2004, 10: 265-271.
  • 6Dall'Igna OP, Da Silva AL, Dietrich MO, et al. Chronic treatment with caffeine blunts the hyperIocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice. Psychopharmacology (Bed), 2003, 166: 258-263.
  • 7Martini C, Tuscano D, Trincavelli ML, et al. Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsyehotics. J Psychiatr Res, 2006, 40 : 81-88.
  • 8Vanichakarn P, Blair P, Wu C, et al. Neutrophil CD40 enhances platelet-mediated inflammation. Thromb Res, 2008, 122 : 346- 358.
  • 9Ghisolfi ES, Prokopiuk AS, Becker J, et al. The adenosine antagonist theophylline impairs Ps0 auditory sensory gating in normal subjects. Neuropsychopharmacology, 2002, 27: 629~37.
  • 10Lucas PB, Pickar D, Kelsoe J, et al. Effects of the acute administration of caffeine in patients with schizophrenia. Biol Psychiatry, 1990, 28: 35-40.

同被引文献25

  • 1胡大一,许俊堂.加强血栓相关疾病防治研究[J].医学研究通讯,2005,34(10):5-5. 被引量:1
  • 2陈琪,宋梓祥,徐乐平.氯氮平、利培酮、氯丙嗪对糖代谢影响的对照研究[J].中国健康心理学杂志,2007,15(4):382-383. 被引量:2
  • 3Capasso R M,Lineberry T W,Bostwiek J M,et al.Mortality in schizophrenia and schizoaffective disorder:An olmsted county,minnesota cohort 1950-2005[J].Schizophr Res,2008,98(2):287-294.
  • 4Barr W.Physical health of people with severe mental illness[J].BMJ,2001,323(4):321-322.
  • 5Von Hansswoff-Juhlin Y,Sjartveit M,Lindstrsm E,et a1.Schizophrenia and physical health problems[J].Acta Psychiatr Scand,2009,119(438):15-21.
  • 6Rumpf T H,Krizmaric M,Grmee S,et a1.Capnometry in SUS-peeted pulmonary embolism with positive D-dimer in the field[J].Clin Care,2009,13(6):196-201.
  • 7Madzhuga A V,Somonova O V,Elizarova A L,et a1.The clinical value of D-dimer in the diagnosis and treatment of thromboembolic complications and DIC syndrome in cancer patients[J].Anesteziol Reanimatol,2005(5):55-59.
  • 8Giuseppe L,Massimo F,Giovanni T,et al.Help me,doctor!My Ddime is raised[J].Ann Med,2008,40(8):549-550.
  • 9Penaloza A,Roy P M,Kline J,et al.Performance of aged-adjusted D-dimer cut-off to rule out pulmonary embolism[J].J thromb Haemoat,2012,10(7):1291-1296.
  • 10Palareti G,Cosmi B,Leganni C.D-dimer testing to determine the duration of anticoagulation therapy[J].Curr Opin Pulm Med,2007,13(5):393-341.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部